 | • レポートコード：B-GIR09D4177 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、経口抗糖尿病薬の世界市場について調べ、まとめました。種類別セグメントは、スルホニルウレア、メグリチニド、ビグアナイド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤等、用途別セグメントは、家庭用、医療機関、その他等に区分しました。経口抗糖尿病薬の世界市場概観、企業動向、企業別経口抗糖尿病薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・経口抗糖尿病薬の市場概観 ・経口抗糖尿病薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・経口抗糖尿病薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・経口抗糖尿病薬の世界市場規模 ・経口抗糖尿病薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・経口抗糖尿病薬のアメリカ市場規模推移 ・経口抗糖尿病薬のカナダ市場規模推移 ・経口抗糖尿病薬のメキシコ市場規模推移 ・経口抗糖尿病薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・経口抗糖尿病薬のドイツ市場規模推移 ・経口抗糖尿病薬のイギリス市場規模推移 ・経口抗糖尿病薬のロシア市場規模推移 ・経口抗糖尿病薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・経口抗糖尿病薬の日本市場規模推移 ・経口抗糖尿病薬の中国市場規模推移 ・経口抗糖尿病薬の韓国市場規模推移 ・経口抗糖尿病薬のインド市場規模推移 ・経口抗糖尿病薬の東南アジア市場規模推移 ・経口抗糖尿病薬の南米市場分析（ブラジル、アルゼンチン等） ・経口抗糖尿病薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・経口抗糖尿病薬の種類別分析/販売量、売上、市場シェア（スルホニルウレア、メグリチニド、ビグアナイド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤） ・経口抗糖尿病薬の用途別分析/市場規模（家庭用、医療機関、その他） ・経口抗糖尿病薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・経口抗糖尿病薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
Scope of the Report:
The global Oral Antidiabetic Agents market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oral Antidiabetic Agents.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Oral Antidiabetic Agents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oral Antidiabetic Agents market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors
Market Segment by Applications, can be divided into
Home Use
Medical Institutions
Others
Table of Contents
1 Oral Antidiabetic Agents Market Overview
1.1 Product Overview and Scope of Oral Antidiabetic Agents
1.2 Classification of Oral Antidiabetic Agents by Types
1.2.1 Global Oral Antidiabetic Agents Revenue Comparison by Types (2019-2024)
1.2.2 Global Oral Antidiabetic Agents Revenue Market Share by Types in 2018
1.2.3 Sulfonylureas
1.2.4 Meglitinides
1.2.5 Biguanides
1.2.6 Thiazolidinediones
1.2.7 Alpha-glucosidase Inhibitors
1.3 Global Oral Antidiabetic Agents Market by Application
1.3.1 Global Oral Antidiabetic Agents Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Global Oral Antidiabetic Agents Market by Regions
1.4.1 Global Oral Antidiabetic Agents Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Oral Antidiabetic Agents Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oral Antidiabetic Agents Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oral Antidiabetic Agents Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Oral Antidiabetic Agents Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oral Antidiabetic Agents Status and Prospect (2014-2024)
1.5 Global Market Size of Oral Antidiabetic Agents (2014-2024)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Oral Antidiabetic Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Oral Antidiabetic Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Oral Antidiabetic Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Oral Antidiabetic Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva
2.5.1 Business Overview
2.5.2 Oral Antidiabetic Agents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Oral Antidiabetic Agents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.7 Wockhardt UK
2.7.1 Business Overview
2.7.2 Oral Antidiabetic Agents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.8 Merck
2.8.1 Business Overview
2.8.2 Oral Antidiabetic Agents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Oral Antidiabetic Agents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
2.10 Cipla
2.10.1 Business Overview
2.10.2 Oral Antidiabetic Agents Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oral Antidiabetic Agents Market Competition, by Players
3.1 Global Oral Antidiabetic Agents Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Oral Antidiabetic Agents Players Market Share
3.2.2 Top 10 Oral Antidiabetic Agents Players Market Share
3.3 Market Competition Trend
4 Global Oral Antidiabetic Agents Market Size by Regions
4.1 Global Oral Antidiabetic Agents Revenue and Market Share by Regions
4.2 North America Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
4.3 Europe Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
4.5 South America Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
5 North America Oral Antidiabetic Agents Revenue by Countries
5.1 North America Oral Antidiabetic Agents Revenue by Countries (2014-2019)
5.2 USA Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
5.3 Canada Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
5.4 Mexico Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
6 Europe Oral Antidiabetic Agents Revenue by Countries
6.1 Europe Oral Antidiabetic Agents Revenue by Countries (2014-2019)
6.2 Germany Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
6.3 UK Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
6.4 France Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
6.5 Russia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
6.6 Italy Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Oral Antidiabetic Agents Revenue by Countries
7.1 Asia-Pacific Oral Antidiabetic Agents Revenue by Countries (2014-2019)
7.2 China Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
7.3 Japan Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
7.4 Korea Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
7.5 India Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
8 South America Oral Antidiabetic Agents Revenue by Countries
8.1 South America Oral Antidiabetic Agents Revenue by Countries (2014-2019)
8.2 Brazil Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
8.3 Argentina Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
8.4 Colombia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Oral Antidiabetic Agents by Countries
9.1 Middle East and Africa Oral Antidiabetic Agents Revenue by Countries (2014-2019)
9.2 Saudi Arabia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
9.3 UAE Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
9.4 Egypt Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
9.5 Nigeria Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
9.6 South Africa Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
10 Global Oral Antidiabetic Agents Market Segment by Type
10.1 Global Oral Antidiabetic Agents Revenue and Market Share by Type (2014-2019)
10.2 Global Oral Antidiabetic Agents Market Forecast by Type (2019-2024)
10.3 Sulfonylureas Revenue Growth Rate (2014-2024)
10.4 Meglitinides Revenue Growth Rate (2014-2024)
10.5 Biguanides Revenue Growth Rate (2014-2024)
10.6 Thiazolidinediones Revenue Growth Rate (2014-2024)
10.7 Alpha-glucosidase Inhibitors Revenue Growth Rate (2014-2024)
11 Global Oral Antidiabetic Agents Market Segment by Application
11.1 Global Oral Antidiabetic Agents Revenue Market Share by Application (2014-2019)
11.2 Oral Antidiabetic Agents Market Forecast by Application (2019-2024)
11.3 Home Use Revenue Growth (2014-2019)
11.4 Medical Institutions Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Oral Antidiabetic Agents Market Size Forecast (2019-2024)
12.1 Global Oral Antidiabetic Agents Market Size Forecast (2019-2024)
12.2 Global Oral Antidiabetic Agents Market Forecast by Regions (2019-2024)
12.3 North America Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
12.4 Europe Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
12.6 South America Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Oral Antidiabetic Agents Picture
Table Product Specifications of Oral Antidiabetic Agents
Table Global Oral Antidiabetic Agents and Revenue (Million USD) Market Split by Product Type
Figure Global Oral Antidiabetic Agents Revenue Market Share by Types in 2018
Figure Sulfonylureas Picture
Figure Meglitinides Picture
Figure Biguanides Picture
Figure Thiazolidinediones Picture
Figure Alpha-glucosidase Inhibitors Picture
Table Global Oral Antidiabetic Agents Revenue (Million USD) by Application (2014-2024)
Figure Oral Antidiabetic Agents Revenue Market Share by Applications in 2018
Figure Home Use Picture
Figure Medical Institutions Picture
Figure Others Picture
Table Global Market Oral Antidiabetic Agents Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (2014-2024)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Oral Antidiabetic Agents Type and Applications
Table Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Oral Antidiabetic Agents Type and Applications
Table Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Oral Antidiabetic Agents Type and Applications
Table Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Oral Antidiabetic Agents Type and Applications
Table Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Oral Antidiabetic Agents Type and Applications
Table Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Oral Antidiabetic Agents Type and Applications
Table AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Wockhardt UK Basic Information, Manufacturing Base and Competitors
Table Wockhardt UK Oral Antidiabetic Agents Type and Applications
Table Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oral Antidiabetic Agents Type and Applications
Table Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oral Antidiabetic Agents Type and Applications
Table Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Oral Antidiabetic Agents Type and Applications
Table Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Global Oral Antidiabetic Agents Revenue (Million USD) by Players (2014-2019)
Table Global Oral Antidiabetic Agents Revenue Share by Players (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Share by Players in 2017
Figure Global Oral Antidiabetic Agents Revenue Share by Players in 2018
Figure Global Top 5 Players Oral Antidiabetic Agents Revenue Market Share in 2018
Figure Global Top 10 Players Oral Antidiabetic Agents Revenue Market Share in 2018
Figure Global Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Oral Antidiabetic Agents Revenue (Million USD) by Regions (2014-2019)
Table Global Oral Antidiabetic Agents Revenue Market Share by Regions (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Market Share by Regions (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Market Share by Regions in 2018
Figure North America Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Europe Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure South America Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Table North America Oral Antidiabetic Agents Revenue by Countries (2014-2019)
Table North America Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure North America Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure North America Oral Antidiabetic Agents Revenue Market Share by Countries in 2018
Figure USA Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Canada Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Mexico Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Table Europe Oral Antidiabetic Agents Revenue (Million USD) by Countries (2014-2019)
Figure Europe Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure Europe Oral Antidiabetic Agents Revenue Market Share by Countries in 2018
Figure Germany Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure UK Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure France Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Russia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Italy Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Oral Antidiabetic Agents Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Oral Antidiabetic Agents Revenue Market Share by Countries in 2018
Figure China Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Japan Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Korea Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure India Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Table South America Oral Antidiabetic Agents Revenue by Countries (2014-2019)
Table South America Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure South America Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure South America Oral Antidiabetic Agents Revenue Market Share by Countries in 2018
Figure Brazil Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Argentina Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Colombia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Oral Antidiabetic Agents Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Antidiabetic Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Antidiabetic Agents Revenue Market Share by Countries in 2018
Figure Saudi Arabia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure UAE Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Egypt Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure Nigeria Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Figure South Africa Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
Table Global Oral Antidiabetic Agents Revenue (Million USD) by Type (2014-2019)
Table Global Oral Antidiabetic Agents Revenue Share by Type (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Share by Type (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Share by Type in 2019
Table Global Oral Antidiabetic Agents Revenue Forecast by Type (2019-2024)
Figure Global Oral Antidiabetic Agents Market Share Forecast by Type (2019-2024)
Figure Global Sulfonylureas Revenue Growth Rate (2014-2019)
Figure Global Meglitinides Revenue Growth Rate (2014-2019)
Figure Global Biguanides Revenue Growth Rate (2014-2019)
Figure Global Thiazolidinediones Revenue Growth Rate (2014-2019)
Figure Global Alpha-glucosidase Inhibitors Revenue Growth Rate (2014-2019)
Table Global Oral Antidiabetic Agents Revenue by Application (2014-2019)
Table Global Oral Antidiabetic Agents Revenue Share by Application (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Share by Application (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue Share by Application in 2019
Table Global Oral Antidiabetic Agents Revenue Forecast by Application (2019-2024)
Figure Global Oral Antidiabetic Agents Market Share Forecast by Application (2019-2024)
Figure Global Home Use Revenue Growth Rate (2014-2019)
Figure Global Medical Institutions Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Oral Antidiabetic Agents Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Oral Antidiabetic Agents Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Oral Antidiabetic Agents Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
Figure Europe Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
Figure South America Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
世界の口腔疾患治療市場予測（～2024年） Oral diseases ranging from cavities to cancer are all serious threats to your oral health. Scope of the Report: The global Oral Diseases Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. T…- 世界の内視鏡検査薬市場予測（～2024年） Chromoendoscopy is a medical procedure wherein dyes (often the same stains used in histology) are instilled into the gastrointestinal tract at the time of visualization with fibre-optic endoscopy. The purposes of chromoendoscopy is chiefly enhance the characterization of tissues, although dyes may b…
- 世界のシリカベース艶消剤市場予測（～2024年） Matting agents help control the gloss of the surface on which they are applied. These agents are fine particles that are dispersed in paint and coating formulations in such a way that they scatter the light falling on the surface in a desired, defined manner. Scope of the Report: The worldwide marke…
- 世界の防食剤市場予測（～2024年） Anti corrosion agents are chemical substances or compounds that, when present in the environment (medium) in the appropriate concentration and form, can prevent or slow down corrosion of materials. Scope of the Report: The worldwide market for Anti Corrosion Agents is expected to grow at a CAGR of r…
- 世界のゲル化剤・乳化剤・安定剤市場予測（～2024年） Scope of the Report: The worldwide market for Gelling Agents, Emulsifiers and Stabilizers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on…